Top Markets
#1 Black Phoenix Black Phoenix +355.09%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.35%
#4 Akedo Akedo +59.66%
#5 OpenEden OpenEden +47.92%
#6 Acurast Acurast +30.29%
#7 BasedHype BasedHype +27.23%
#8 Cryptopia Cryptopia +21.54%
#9 Avantis Avantis +20.78%
#10 Humanity Humanity +16.94%
Coin of the day
Black Phoenix Black Phoenix
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Alligator Bioscience AB (publ) Alligator Bioscience AB (publ)

Alligator Bioscience AB (publ)

ATORX
Helyezés a részvények között #40436
Alligator Bioscience AB (publ) is a research-intensive biotechnology company... Alligator Bioscience AB (publ) is a research-intensive biotechnology company based in Lund, Sweden, focused on developing innovative antibody-based treatments for cancer. The company leverages several proprietary technology platforms to drive its drug development. These include ALLIGATOR-GOLD and ALLIGATOR-FAB, an extensive human antibody library boasting roughly 60 billion distinct antibody fragments; FIND, a molecular evolution technique used for optimizing antibodies and other proteins; and RUBY, a specialized format for creating bispecific antibodies. Alligator Bioscience's pipeline features several promising candidates. In the clinical stage, Mitazalimab, an immunostimulatory CD40 antibody, has successfully completed Phase I trials for metastatic cancer. Also undergoing Phase I clinical evaluation is ATOR-1017, another immunostimulatory antibody designed to bind to the 4-1BB receptor on tumor-specific T cells. For its preclinical efforts, the company is advancing ALG.APV-527, a bispecific antibody targeting both 4-1BB and 5T4 for cancer therapy. Additionally, Alligator Bioscience holds an interest in the Biosynergy (AC101) project, which is currently in Phase I. To bolster its research and development capabilities, Alligator Bioscience has formed multiple strategic collaborations. It has a co-development partnership with Aptevo Therapeutics Inc. for ALG.APV-527, and a research alliance with MacroGenics, Inc. to create novel immunotherapies. Further collaborations include a joint research agreement with BioArctic AB (publ) to utilize proprietary antibody generation technologies for new product candidates, and a research and license agreement with Orion Corporation aimed at discovering and developing new bispecific antibody cancer therapeutics. The company was established in 2000.
Részvényárfolyam
$0.00408798
Piaci kapitalizáció
$147.44K
Változás (1 nap)
-0.54%
Változás (1 év)
-99.17%
Ország
SE
Kereskedés Alligator Bioscience AB (publ) (ATORX)

Kategória

Healthcare
Alligator Bioscience AB (publ) (ATORX) részvényárfolyamának története
Legmagasabb napi záróár: $0.00 ekkor: 2026-08-01

Legalacsonyabb napi záróár: $3.38K ekkor: 2016-11-01
Alligator Bioscience AB (publ) részvényárfolyamának története 2016 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2026 (TTM) 211.40%
2025 -99.84%
2024 -61.76%
2023 -60.05%
2022 -38.34%
2021 -66.79%
2020 -24.00%
2019 -56.79%
2018 -6.64%
2017 -20.92%
2016 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE